Tamil Nadu has received two consignments of Covifor, a generic version of the experimental COVID-19 drug remdesivir, from Hyderabad-based Hetero, and has dispatched them to all districts for treatment of critical COVID-19 patients.
The State received the first consignment of 1,000 vials on Wednesday and another on Thursday. The first consignment has already been distributed to all government hospitals in the State. “We have ordered a consignment of 42,500 vials of the medicine, the largest number ordered by any State till date. We have dispatched the first consignment and it has already reached all government hospitals, medical college hospitals and district headquarters hospitals in districts where there are no medical colleges. In fact, we got some quantity for compassionate use last week itself,” Umanath, managing director, Tamil Nadu Medical Services Corporation, said
Dr. Umanath said that Tamil Nadu was the first State to distribute the drug to every district. “Others are using it in select hospitals. We are making it universally available so that it becomes easier to treat patients in all districts,” he said. The State is expecting another consignment of a few more thousand vials.
You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in
Show Less Plan
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Faster pages
Move smoothly between articles as our pages load instantly.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Personalised recommendations
A select list of articles that match your interests and tastes.
Briefing
We brief you on the latest and most important developments, three times a day.
*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath